Avaliação sobre a eficácia e segurança da vacina contra influenza – Parte II

Jardel Corrêa Oliveira, Ana Cristina Vidor, Rodrigo D’Agostini Derech

Palavras-chave


vacinas, influenza humana

Texto completo:

PDF

Referências


Thomas RE, Jefferson T, Lasserson TJ. Influenza vaccination for healthcare workers who care for people aged 60 or older living in long-term care institutions. Cochrane Database Syst Rev. 2013;7:CD005187. Epub 2013/07/25.

Dolan GP, Harris RC, Clarkson M, et al. Vaccination of health care workers to protect patients at increased risk for acute respiratory disease. Emerg Infect Dis. 2012;18(8):1225-34. Epub 2012/07/31.

Jordan R, Wake B, Hawker J, et al. Influenza vaccination of health care workers (HCW) to reduce Influenza-related outcomes in high risk patients: a systematic review of clinical and cost-effectiveness. Health Technology Assessment (HTA) Database. 2004.

Loomba RS, Aggarwal S, Shah PH, et al. Influenza vaccination and cardiovascular morbidity and mortality: analysis of 292,383 patients. J Cardiovasc Pharmacol Ther. 2012;17(3):277-83. Epub 2011/12/17.

Udell JA, Zawi R, Bhatt DL, Keshtkar-Jahromi M, Gaughran F, Phrommintikul A, et al. Association between Influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis. JAMA 2013;310(16):1711-20. Epub 2013/10/24.

Chang CC, Morris PS, Chang AB. Influenza vaccine for children and adults with bronchiectasis. Cochrane Database Syst Rev.. 2010(9):CD006218.

Poole P, Chacko EE, Wood-Baker R, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2010(8):CD002733.

Cates CJ, Rowe BH. Vaccines for preventing Influenza in people with asthma. Cochrane Database Syst Rev.. 2013;2:CD000364. Epub 2013/03/02.

Dharmaraj P, Smyth RL. Vaccines for preventing Influenza in people with cystic fibrosis. Cochrane Database Syst Rev. 2011(8):CD001753.

Goossen GM, Kremer LCM, van de Wetering MD. Influenza vaccination in children being treated with chemotherapy for cancer. Cochrane Database Syst Rev. 2013(8):CD006484.

Cheuk DK, Chiang AK, Lee TL, Chan GC, Ha SY. Vaccines for prophylaxis of viral infections in patients with hematological malignancies. Cochrane Database Syst Rev. 2011(3):CD006505. Epub 2011/03/18.

Beck CR, McKenzie BC, Hashim AB, Harris RC, Nguyen-Van-Tam JS. Influenza vaccination for immunocompromised patients: systematic review and metaanalysis by etiology. J Infect Dis. 2012;206(8):1250-9. Epub 2012/08/21.

Yin JK, Chow MY, Khandaker G, et al. Impacts on Influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent Influenza vaccines and A(H1N1)pdm09 vaccines: systematic review and meta-analyses. Vaccine. 2012;30(21):3209-22. Epub 2012/03/06.

Luna EJ, Gattas VL. Effectiveness of the Brazilian Influenza vaccination policy, a systematic review. Rev Inst Med Trop Sao Paulo. 2010;52(4):175-81. Epub 2011/07/13.

Kuo AM, Brown JN, Clinard V. Effect of Influenza vaccination on international normalized ratio during chronic warfarin therapy. J Clin Pharm Ther. 2012;37(5):505-9. Epub 2012/03/28.

Rutschmann OT, McCrory DC, Matchar DB. Immunization and MS: a summary of published evidence and recommendations. Neurology. 2002;59:1837-47.

Beyer WE, Palache AM, Osterhaus AD.Comparison of Serology and Reactogenicity between Influenza Subunit Vaccines and Whole Virus or Split Vaccines: A Review and Meta-Analysis of the Literature. Clin Drug Investig. 1998;15(1):1-12.18. Manzoli L, De Vito C, Salanti G, D’Addario M, Villari P, Ioannidis JP. Metaanalysis of the immunogenicity and tolerability of pandemic Influenza A 2009 (H1N1) vaccines. PloS One. 2011;6(9):e24384. Epub 2011/09/15.

Marra F, Young F, Richardson K, Marra CA. A metaanalysis of intradermal versus intramuscular Influenza vaccines: immunogenicity and adverse events. Influenza Other Respir Viruses. 2013;7(4):584-603. Epub 2012/09/15.


Apontamentos

  • Não há apontamentos.